Health and Happiness (H&H) International Holdings (1112) AI Stock Analysis

• Market Cap: $7.64B
• Dividend Yield: 5.27%
• Average Volume (3M): 3.71M
• Price to Earnings (P/E): 22.0
• Beta (1Y): 0.90
• Revenue Growth: -8.10%
• EPS Growth: -108.48%
• Country: HK
• Employees: 2,800
• Sector: Healthcare
• Sector Strength: 41
• Industry: Packaged Foods
• EPS (TTM): -0.09
• Shares Outstanding: 645,561,340
• 10 Day Avg. Volume: 6,678,764
• 30 Day Avg. Volume: 3,706,594
• PEG Ratio: -0.40
• Price to Book (P/B): 0.91
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 2.85
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $11.26
• Price Target Upside: -3.43% Downside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

Health and Happiness (H&H) International Holdings shows strong cash flow and gross margins, supporting its financial stability despite a net loss and high leverage. The technical analysis indicates positive momentum, albeit with caution due to potential overbought conditions. Valuation is negatively impacted by a high P/E ratio but offset by a strong dividend yield. Strategic improvements in revenue and profitability are crucial for future growth.

Health and Happiness (H&H) International Holdings Business Overview & Revenue Model

Company Description

Health and Happiness (H&H) International Holdings Limited (1112) is a global health and wellness company that operates in three primary sectors: infant and adult nutrition, vitamins and supplements, and personal care. The company is known for its portfolio of premium brands, including Biostime, Swisse, and Dodie, which are designed to support the health and well-being of consumers across various stages of life.

How the Company Makes Money

H&H International Holdings generates revenue through the sale of its diverse range of products in the infant nutrition, adult nutrition, and personal care markets. The company's key revenue streams include the sale of infant formula and baby food under the Biostime brand; vitamins, minerals, and supplements through the Swisse brand; and personal care products under brands like Dodie. H&H leverages a multi-channel distribution strategy, including e-commerce platforms, retail partnerships, and direct-to-consumer sales, to reach a broad customer base globally. Strategic partnerships and acquisitions, such as the acquisition of Swisse Wellness, have also played a significant role in expanding the company's product offerings and market reach, contributing to its revenue growth.

Health and Happiness (H&H) International Holdings Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement		Total Revenue
13.64B	13.93B	12.78B	11.55B	11.19B	10.93B
	Gross Profit
8.33B	8.47B	7.70B	7.25B	7.19B	7.23B
	EBIT
1.66B	1.83B	1.45B	1.09B	1.86B	1.98B
	EBITDA
1.83B	2.04B	1.87B	1.42B	2.13B	2.18B
	Net Income Common Stockholders
279.63M	581.85M	611.78M	508.48M	1.14B	1.01B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
1.73B	1.45B	2.30B	2.40B	1.83B	2.22B
	Total Assets
1.90B	20.04B	20.96B	20.28B	17.22B	15.86B
	Total Debt
0.00	9.22B	9.67B	9.48B	6.17B	6.04B
	Net Debt
-1.73B	7.86B	7.37B	7.08B	4.34B	3.82B
	Total Liabilities
242.11M	13.75B	14.82B	14.40B	11.02B	10.27B
	Stockholders Equity
1.66B	6.30B	6.14B	5.89B	6.20B	5.59B
Cash Flow		Free Cash Flow
2.08B	1.01B	1.37B	1.78B	1.43B	1.31B
	Operating Cash Flow
2.13B	1.10B	1.47B	1.89B	1.53B	1.44B
	Investing Cash Flow
-24.37M	-52.07M	-104.88M	-4.01B	-1.24B	-277.19M
	Financing Cash Flow
-1.88B	-1.99B	-1.49B	2.77B	-687.68M	-869.12M

Health and Happiness (H&H) International Holdings Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 11.66
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1112, the sentiment is Positive. The current price of 11.66 is above the 20-day moving average (MA) of 9.25, above the 50-day MA of 9.41, and above the 200-day MA of 9.07, indicating a bullish trend. The MACD of 0.34 indicates Negative momentum. The RSI at 76.04 is Negative, neither overbought nor oversold. The STOCH value of 87.35 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1112.

Health and Happiness (H&H) International Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1093	76 Outperform	$67.73B	14.73	13.20%	5.99%	-9.60%	-27.18%
1513	74 Outperform	$31.13B	10.72	14.56%	5.58%	-5.37%	6.28%
1113	71 Outperform	$114.79B	8.44	3.52%	6.99%	-3.04%	-20.01%
1112	68 Neutral	$7.64B	21.96	-0.91%	5.27%	-8.10%	-108.48%
2319	68 Neutral	$71.91B	636.68	0.21%	2.92%	-11.90%	-97.93%
3320	62 Neutral	€31.10B	8.56		5.60%	―	―
Sector *	52 Neutral	$5.19B	3.04	-44.64%	2.82%	16.45%	-0.53%

Health and Happiness (H&H) International Holdings Corporate Events

H&H International Holdings Passes Key Resolutions at AGM

Health and Happiness (H&H) International Holdings Limited held its Annual General Meeting on May 12, 2025, where all proposed resolutions were passed by poll. Key resolutions included the adoption of financial statements, declaration of a final dividend, re-election of directors, re-appointment of auditors, and granting of mandates to the board for share issuance and repurchase. These decisions reflect the company’s strategic direction and commitment to shareholder value, potentially impacting its market positioning and operational capabilities.

The most recent analyst rating on (HK:1112) stock is a Buy with a HK$13.10 price target. To see the full list of analyst forecasts on Health and Happiness (H&H) International Holdings stock, see the HK:1112 Stock Forecast page.

H&H International Holdings Sees Strong Q1 2025 Revenue Growth

Health and Happiness (H&H) International Holdings Limited reported a 10.4% increase in total revenue for the first quarter of 2025, driven by a strong recovery in mainland China and growth in core markets. The company’s infant milk formula business led the growth with a 46.9% increase, contributing significantly to the Baby Nutrition and Care segment’s 25.3% rise. The Adult Nutrition & Care and Pet Nutrition & Care segments also saw growth, supported by high-margin nutritional supplements which made up 65.1% of total revenue. The company maintained a healthy liquidity position with a cash balance of RMB1.4 billion.

H&H International Holdings Announces 2025 Annual General Meeting

Health and Happiness (H&H) International Holdings Limited has announced its upcoming Annual General Meeting scheduled for May 12, 2025, in Hong Kong. Key agenda items include the adoption of the 2024 financial statements, declaration of a final dividend, re-election of directors, re-appointment of auditors, and a resolution to grant the board a mandate to issue additional shares. These decisions are significant as they reflect the company’s ongoing governance practices and financial strategies, potentially impacting shareholder value and market positioning.

H&H International Holdings Reports 2024 Financial Decline

Health and Happiness (H&H) International Holdings Limited reported a challenging financial year for 2024, with a decline in revenue by 6.3% to RMB 13,051.7 million and a significant drop in net profit, resulting in a net loss of RMB 53.7 million compared to a profit of RMB 581.8 million in 2023. The company’s EBITDA and adjusted EBITDA also saw decreases, reflecting the impact of increased non-cash and non-recurring losses. This financial performance may affect the company’s market positioning and stakeholder confidence, as it navigates through these economic challenges.

H&H International Holdings Declares Final Dividend for 2024

Health and Happiness (H&H) International Holdings Limited has announced a final ordinary cash dividend of HKD 0.05 per share for the financial year ending December 31, 2024. This announcement reflects the company’s financial performance and commitment to returning value to shareholders, with the payment date set for July 9, 2025, following shareholder approval on May 12, 2025. The dividend declaration may enhance shareholder confidence and influence the company’s market positioning positively.

H&H International Reports Revenue Decline Amidst Growth in Key Segments

Health and Happiness (H&H) International Holdings Limited reported a mid-single-digit decrease in total revenue for the year ended December 31, 2024, with strong growth in nutritional supplements offset by declines in the infant milk formula segment. Despite challenges, the company increased its market share in the super-premium infant milk formula segment in mainland China. The Adult Nutrition and Care segment saw high single-digit growth, driven by demand in core markets and innovative products, while the Baby Nutrition and Care segment faced a double-digit decline. The Pet Nutrition and Care segment achieved single-digit growth, with efforts focused on product portfolio premiumisation and channel optimisation. Financially, the company expects a mid-teens Adjusted EBITDA margin, although a decline of 10%-15% compared to the previous year is anticipated.

H&H International Holdings Announces Upcoming Board Meeting for Annual Results

Health and Happiness (H&H) International Holdings Limited has announced that its board of directors will meet on March 25, 2025, to consider and approve the company’s annual results for the year ending December 31, 2024. The meeting will also discuss the recommendation of a final dividend and handle other business matters. This meeting is significant as it will determine the company’s financial performance and dividend policy, impacting shareholders and market positioning.